Visumab 0.5mg Injection
Marketer
Reliance Life Sciences
Salt Composition
Ranibizumab (0.5mg)
Overview Visumab 0.5mg Injection
Diabetic retinopathy, macular degeneration, and macular edema are treated with a 0.5mg Visumab injection. This medication targets abnormal blood vessel growth and leakage in the eye, a leading cause of vision impairment. Administered directly into the eye by an ophthalmologist, self-injection is strictly prohibited. Potential side effects include conjunctival bleeding, ocular pain, floaters, elevated intraocular pressure, and eye inflammation. Persistent side effects or any concerning symptoms warrant immediate medical attention. Driving is discouraged following injection due to potential visual blurring.
Uses of Visumab 0.5mg Injection
Retinopathy in diabetes | Neovascular age-related macular degeneration | Macular swelling from retinal vein blockage
Major Benefits of Visumab 0.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Visumab 0.5mg Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Visumab 0.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Visumab 0.5mg Injection works:
Visumab 0.5mg Injection, an anti-angiogenesis agent, inhibits vascular endothelial growth factor (VEGF), thereby preventing the formation and permeability of aberrant ocular blood vessels, which can lead to visual impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Visumab 0.5mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Visumab 0.5mg Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Visumab 0.5mg Injection safely. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Following administration of Visumab 0.5mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Visumab 0.5mg Injection appears to be well-tolerated. Existing evidence indicates dose modification may not be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Visumab 0.5mg Injection in patients with liver conditions appears to present a low risk. Current evidence indicates dose modification may be unnecessary for this population. However, physician consultation is recommended.
What if you forget to take Visumab 0.5mg Injection :
Should you forget a Visumab 0.5mg Injection, seek your physician's advice.
Facts to Know About Visumab 0.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Behavior Class | Anti-VEGF therapy for age-related macular degeneration |
3,018 People bought this recently